References
1 Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A,
et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence
and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer
J Clin 2021;71:209-249.
2 Diseases GBD & Injuries C. Global burden of 369 diseases and injuries
in 204 countries and territories, 1990-2019: a systematic analysis for
the Global Burden of Disease Study 2019. Lancet2020;396:1204-1222.
3 Lheureux S, Gourley C, Vergote I & Oza AM. Epithelial ovarian cancer.Lancet 2019;393:1240-1253.
4 Lu KH & Broaddus RR. Endometrial Cancer. N Engl J Med2020;383:2053-2064.
5 Stevens GA, Alkema L, Black RE, Boerma JT, Collins GS, Ezzati M, et
al. Guidelines for Accurate and Transparent Health Estimates Reporting:
the GATHER statement. PLoS Med 2016;13:e1002056.
6 Collaborators GBDD. Global age-sex-specific fertility, mortality,
healthy life expectancy (HALE), and population estimates in 204
countries and territories, 1950-2019: a comprehensive demographic
analysis for the Global Burden of Disease Study 2019. Lancet2020;396:1160-1203.
7 Wang Z, Guo E, Yang B, Xiao R, Lu F, You L, et al. Trends and
age-period-cohort effects on mortality of the three major gynecologic
cancers in China from 1990 to 2019: Cervical, ovarian and uterine
cancer. Gynecol Oncol 2021;163:358-363.
8 Global Burden of Disease Study C. Global, regional, and national
incidence, prevalence, and years lived with disability for 301 acute and
chronic diseases and injuries in 188 countries, 1990-2013: a systematic
analysis for the Global Burden of Disease Study 2013. Lancet2015;386:743-800.
9 Soerjomataram I, Lortet-Tieulent J, Parkin DM, Ferlay J, Mathers C,
Forman D, et al. Global burden of cancer in 2008: a systematic analysis
of disability-adjusted life-years in 12 world regions. Lancet2012;380:1840-1850.
10 Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer
statistics in China, 2015. CA Cancer J Clin 2016;66:115-132.
11 Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et
al. Cancer incidence and mortality worldwide: sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359-386.
12 Hu Y, Ma Z, Zhang H, Gao T, Gao J, Kong Y, et al. Prevalence of and
factors related to anxiety and depression symptoms among married
patients with gynecological malignancies in China. Asian J
Psychiatr 2018;37:90-95.
13 Perez-Tejada J, Labaka A, Pascual-Sagastizabal E, Garmendia L,
Iruretagoyena A & Arregi A. Predictors of psychological distress in
breast cancer survivors: A biopsychosocial approach. Eur J Cancer
Care (Engl) 2019;28:e13166.
14 Li WJ, Miao M, Gan YQ, Zhang ZJ & Cheng G. The relationship between
meaning discrepancy and emotional distress among patients with cancer:
the role of posttraumatic growth in a collectivistic culture. Eur
J Cancer Care (Engl) 2016;25:491-501.
15 Hsu HC, Tsai SY, Wu SL, Jeang SR, Ho MY, Liou WS, et al. Longitudinal
perceptions of the side effects of chemotherapy in patients with
gynecological cancer. Support Care Cancer 2017;25:3457-3464.
16 Lee JT, Kuo HY, Huang KG, Lin JR & Chen ML. Diversity of sexual
activity and correlates among women with gynecological cancer.Gynecol Oncol 2020;159:503-508.
17 Yi M, Li A, Zhou L, Chu Q, Song Y & Wu K. The global burden and
attributable risk factor analysis of acute myeloid leukemia in 195
countries and territories from 1990 to 2017: estimates based on the
global burden of disease study 2017. J Hematol Oncol 2020;13:72.
18 Deng Y, Li H, Wang M, Li N, Tian T, Wu Y, et al. Global Burden of
Thyroid Cancer From 1990 to 2017. JAMA Netw Open 2020;3:e208759.
19 Bai X, Yi M, Dong B, Zheng X & Wu K. The global, regional, and
national burden of kidney cancer and attributable risk factor analysis
from 1990 to 2017. Exp Hematol Oncol 2020;9:27.
20 Global Burden of Disease Cancer C, Kocarnik JM, Compton K, Dean FE,
Fu W, Gaw BL, et al. Cancer Incidence, Mortality, Years of Life Lost,
Years Lived With Disability, and Disability-Adjusted Life Years for 29
Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global
Burden of Disease Study 2019. JAMA Oncol 2021;
21 Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, et
al. Estimates of incidence and mortality of cervical cancer in 2018: a
worldwide analysis. Lancet Glob Health 2020;8:e191-e203.
22 Crosbie EJ, Einstein MH, Franceschi S & Kitchener HC. Human
papillomavirus and cervical cancer. Lancet 2013;382:889-899.
23 Bosch FX, Lorincz A, Muñoz N, Meijer CJ & Shah KV. The causal
relation between human papillomavirus and cervical cancer. J Clin
Pathol 2002;55:244-265.
24 Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J,
Bruni L, et al. Global burden of human papillomavirus and related
diseases. Vaccine 2012;30 Suppl 5:F12-23.
25 Small W, Jr., Bacon MA, Bajaj A, Chuang LT, Fisher BJ, Harkenrider
MM, et al. Cervical cancer: A global health crisis. Cancer2017;123:2404-2412.
26 Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, et
al. Prevalence of HPV infection among females in the United States.Jama 2007;297:813-819.
27 Vinodhini K, Shanmughapriya S, Das BC & Natarajaseenivasan K.
Prevalence and risk factors of HPV infection among women from various
provinces of the world. Arch Gynecol Obstet 2012;285:771-777.
28 Cao M, Li H, Sun D, He S, Yu Y, Li J, et al. Cancer screening in
China: The current status, challenges, and suggestions. Cancer
Lett 2021;506:120-127.
29 Natphopsuk S, Settheetham-Ishida W, Sinawat S, Pientong C, Yuenyao P
& Ishida T. Risk factors for cervical cancer in northeastern Thailand:
detailed analyses of sexual and smoking behavior. Asian Pac J
Cancer Prev 2012;13:5489-5495.
30 Sung H, Siegel RL, Torre LA, Pearson-Stuttard J, Islami F, Fedewa SA,
et al. Global patterns in excess body weight and the associated cancer
burden. CA Cancer J Clin 2019;69:88-112.
31 Aubrey C, Black K, Campbell S & Pin S. Endometrial cancer and
bariatric surgery: A scoping review. Surg Obes Relat Dis2019;15:497-501.
32 Lindemann K, Vatten LJ, Ellstrøm-Engh M & Eskild A. The impact of
BMI on subgroups of uterine cancer. Br J Cancer 2009;101:534-536.
33 Scherübl H. [Excess Body Weight and Cancer Risk]. Dtsch Med
Wochenschr 2020;145:1006-1014.
34 Roque DR, Makowski L, Chen TH, Rashid N, Hayes DN & Bae-Jump V.
Association between differential gene expression and body mass index
among endometrial cancers from The Cancer Genome Atlas Project.Gynecol Oncol 2016;142:317-322.
35 Bouleftour W, Mery B, Chanal E, Rowinski E, Viard A, Forges F, et al.
Obesity and chemotherapy administration: between empiric and mathematic
method review. Acta Oncol 2019;58:880-887.
36 Lynch HT, Casey MJ, Snyder CL, Bewtra C, Lynch JF, Butts M, et al.
Hereditary ovarian carcinoma: heterogeneity, molecular genetics,
pathology, and management. Mol Oncol 2009;3:97-137.
37 Zhang Y, Luo G, Li M, Guo P, Xiao Y, Ji H, et al. Global patterns and
trends in ovarian cancer incidence: age, period and birth cohort
analysis. BMC Cancer 2019;19:984.
38 Wang X, Ping FF, Bakht S, Ling J & Hassan W. Immunometabolism
features of metabolic deregulation and cancer. J Cell Mol Med2019;23:694-701.
39 Zhang S, Gong TT, Liu FH, Jiang YT, Sun H, Ma XX, et al. Global,
Regional, and National Burden of Endometrial Cancer, 1990-2017: Results
From the Global Burden of Disease Study, 2017. Front Oncol2019;9:1440.
40 Puente D, López-Jiménez T, Cos-Claramunt X, Ortega Y & Duarte-Salles
T. Metabolic syndrome and risk of cancer: a study protocol of
case-control study using data from the Information System for the
Development of Research in Primary Care (SIDIAP) in Catalonia. BMJ
Open 2019;9:e025365.
41 Olsen CM, Green AC, Whiteman DC, Sadeghi S, Kolahdooz F & Webb PM.
Obesity and the risk of epithelial ovarian cancer: a systematic review
and meta-analysis. Eur J Cancer 2007;43:690-709.
42 Camargo MC, Stayner LT, Straif K, Reina M, Al-Alem U, Demers PA, et
al. Occupational exposure to asbestos and ovarian cancer: a
meta-analysis. Environ Health Perspect 2011;119:1211-1217.
43 Salehi F, Dunfield L, Phillips KP, Krewski D & Vanderhyden BC. Risk
factors for ovarian cancer: an overview with emphasis on hormonal
factors. J Toxicol Environ Health B Crit Rev 2008;11:301-321.
44 Burki T. Asbestos production increases despite WHO opposition.Lancet Oncol 2009;10:846.
45 Bhatla N & Denny L. FIGO Cancer Report 2018. Int J Gynaecol
Obstet 2018;143 Suppl 2:2-3.
46 Sundar S, Balega J, Crosbie E, Drake A, Edmondson R, Fotopoulou C, et
al. BGCS uterine cancer guidelines: Recommendations for practice.Eur J Obstet Gynecol Reprod Biol 2017;213:71-97.
47 Emons G, Steiner E, Vordermark D, Uleer C, Bock N, Paradies K, et al.
Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with
Endometrial Cancer. Guideline (S3-Level, AWMF Registry Number
032/034-OL, April 2018) - Part 2 with Recommendations on the Therapy and
Follow-up of Endometrial Cancer, Palliative Care,
Psycho-oncological/Psychosocial Care/Rehabilitation/Patient Information
and Healthcare Facilities. Geburtshilfe Frauenheilkd2018;78:1089-1109.
48 Cancer Genome Atlas Research N, Kandoth C, Schultz N, Cherniack AD,
Akbani R, Liu Y, et al. Integrated genomic characterization of
endometrial carcinoma. Nature 2013;497:67-73.
TABLE 1 Overall incidence, deaths, DALYs and EAPC from 1990 to
2019 by cervical cancer, uterine cancer and ovarian cancer in China